ASTHMA Flashcards

1
Q

laboratory tests for asthma diagnosis?

A
  1. spirometry: fev1/fvc less than 80%
  2. 12% fev1 increase with brochodialtor
  3. cbc count esnophil increase indicate allergic component. and iges
  4. ABGs: severe distress, suspected hypoventilation, or PEFR or FEV1 30% or less after initial treatment.
    5: pft performed for 5 yrs or older
    6: oximetry to check hypoxemia

Spirometry may be normal if the patient is not symptomatic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Complications of asthma

A

* Status asthmaticus*
Severe, life-threatening attack refractory to usual treatment where patient poses risk for respiratory failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

asthma categories

A

Acute Asthma
Chronic Asthma

* Intermittent Asthma
* Persistent Asthma
Mild
Moderate
Severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Desired Outcomes in Chronic Asthma

A
  • Maintaining Long-term Control
  • using the Least Amount Of Medications
  • Minimizing ADR.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Desired Outcomes in Acute Asthma
treatment goals

A
  • Correct significant hypoxemia
  • Reverse airflow obstruction rapidly
  • Reduce the likelihood of exacerbation relapse or recurrence of severe airflow obstruction in the future
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

non pharmacological treatments of asthma

A
  1. patient education
  2. avoid triggers
  3. vacinnation
  4. avoid medications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Patient education in asthma

A
  • Asthma trigger avoidance
  • Proper administration of inhaled medications
  • Asthma self-management
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

vaccination needed for asthmatic patient

A
  • influenza yearly needed for patient of 6mnths or older
  • Pneumococcal Polysaccharide Vaccine needed dose before age 65 and one after 65
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

drugs that cause asthma

A
  1. non selective Beta Blockers
  2. Aspirin & NSAIDs

For patients with asthma requiring β-blocker therapy, a β1-selective agent is the best option.

asprin sensitivity adults present with rhinitis and nasal polyp with asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the best route of administration of asthma medications & why?

A

Faster onset of action
Lower effective dose
Lower incidence of systemic S.E.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Inhalational Drug Delivery Devices

A

Metered – Dose Inhaler (MDI)
Dry powder inhaler
Soft mist inhaler
Nebulizer: Jet & Ultrasonic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

use of spacer and valve holding chamber with MDI?

A
  • Decrease the need for coordination of actuation with inhalation
  • Decrease oropharyngeal deposition
  • Increase pulmonary drug delivery.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MDI advantages and disadvantage?

A

advantages:
* medication delivery in 2 mins
* portable, durable
* low med dose needed
disadvantage
* techinque / coordinatioon difficult
* Propellant may taste bad or irritate the airways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Proper MDI Technique?

A

Shake the inhaler well
Remove the cap.
2. Exhale all air away from the inhaler.
3. Place the mouthpiece into the mouth with lips closed tightly around the inhaler.
4. To deliver a dose, press down on the canister ONE TIME while inhaling a slow steady breath. A puff of medication is sprayed out of the inhaler into the mouth.
5. Hold your breath for 10 seconds.
6. Exhale from nose.
7. Wait 1-2 minute if the dose is to be repeated.
8. Recap the inhaler when you are finished.
9. Rinse your mouth with water esp. if the medication is inhaled corticosteroid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what If a counter is not available on the inhaler?
For patients who can not hold their breath for 10 seconds?

A

the patient should count the number of puffs used, to determine when the inhaler is empty.

instruct them to hold their breath as long as possible.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

adv and disadvantages of dry power inhalation

A

adv:
1. sweet taste have lactose which is less to caue lactose intolarance
2. easy to use
3. quick delivery of medicine

disadavn:
1. require cordnition
2. not used for children less thn 4 due to high inspirtaory colume
3. less stable after opeing

17
Q

adv and disadv
of soft mist inhaler

A

adv
1. no dry power or propellet
2. better lung deposition

disadv
* require coodination
* challenge to assemble first time use

18
Q

Adult-onset asthma related to

A

atopy, nasal polyps, aspirin sensitivity, occupational exposure, or recurrence of childhood asthma.

19
Q

Ics poor adherence and no response to treatment due to?

A

The main reasons for poor adherence are: the slow onset of action and concerns about systemic SE.
• Considerable variability in response to ICS exists, with up to 40 % of patients not responding to ICS.
• This lack of response may be related to functional glucocorticoid-induced transcript 1 gene variant in some patients with asthma

20
Q

Side effects of inhaled corticosteroids

A

oral candidiasis, cough, and dysphonia.Hoarseness

Decreasing the dose reduces the incidence of hoarseness. Low and medium dose ICS were reported to affect children growth velocity.

21
Q

Systemic corticosteroids
When
Drugs
Dose
Route

A

Prednisolone & methylprednisolone
• acute asthma not responding to SABA
• Their onset of action is 4 - 12 hours, so they need to be started early in the course of acute attack.

The duration of therapy usually ranges from 3 - 10 days. Treatment with systemic corticosteroids should be continued until PEFR is ≥ 70% of the personal best measurement and asthma symptoms are resolved.

22
Q

Early-Phase Response

A

Peaks 30-60 minutes post exposure, subsides 30-90 minutes later

Characterized primarily by bronchospasm

Increased thick sputum secretion with edema formation

Patient experiences wheezing, cough, chest tightness, and dyspnea

23
Q
  1. Late-Phase Response
A

Characterized primarily by inflammation

Histamine and other mediators set up a self-sustaining cycle increasing airways reactivity causing hyper-responsiveness to allergens and other stimuli

Increased airway resistance leads to air trapping in alveoli and hyperinflation of the lungs

If airway inflammation is not treated or does not resolve, may lead to irreversible lung damage

24
Q

Clinical Presentation & Diagnosis of asthma

A

Symptoms:
1. Wheezing
2. Shortness of breath (SoB)
3. Coughing (typically worse at night)
4. Chest tightness

Additional Symptoms:
* Anxiety and agitation
* In acute severe asthma, patients may have difficulty communicating in complete sentences
* Mental status changes (e.g., confusion, irritability, agitation)
* Bradycardia and Absence of wheezing may indicate impending respiratory failure
* Symptoms exacerbated by precipitating factors such as smoke or viral illness
* Symptoms often follow a pattern (e.g., worse at night, seasonal variations)

25
Q

hospitilize patient for acute asthma

A

If patient needed hospitalization: oxygen, continuous nebulization of SABA, systemic corticosteroids (OCS) are used.
Patients with oxygen saturation less than 90% in children, pregnant women, and patients with coexisting heart disease, receive oxygen with the dose adjusted to keep oxygen saturation above 90%.
Administration of low oxygen concentrations (< 30%) by nasal cannula or facemask is usually sufficient to reverse hypoxemia in most patients.

26
Q

Asthma Self-Management

A

freedom to adjust therapy based on personal assessment of disease control using a predetermined plan.
Tools to assess asthma control are: evaluating symptoms of worsening asthma & monitoring PEFR.
Providing patients with a prescription for oral corticosteroids to use PRN for asthma exacerbation is part of asthma self-management.

27
Q

Instructions given to the patient to prevent exercise-induced asthma:

A

Warming up prior to exercise
Covering mouth & nose with a scarf or mask during cold weather.
Pretreatment with SABA or low dose ICS+formoterol 5 - 20 minutes prior to exercise: the treatment of choice and will protect against bronchospasm for 2 - 3 hours.

28
Q
A